Page last updated: 2024-09-05

sk&f 107260 and acetyl-arginyl-glycyl-aspartyl-serinamide

sk&f 107260 has been researched along with acetyl-arginyl-glycyl-aspartyl-serinamide in 1 studies

Compound Research Comparison

Studies
(sk&f 107260)
Trials
(sk&f 107260)
Recent Studies (post-2010)
(sk&f 107260)
Studies
(acetyl-arginyl-glycyl-aspartyl-serinamide)
Trials
(acetyl-arginyl-glycyl-aspartyl-serinamide)
Recent Studies (post-2010) (acetyl-arginyl-glycyl-aspartyl-serinamide)
1100500

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bean, JW; Burgess, JL; Callahan, JF; Eggleston, DS; Hwang, SM; Kopple, KD; Koster, PF; Nichols, A; Peishoff, CE; Samanen, JM1

Other Studies

1 other study(ies) available for sk&f 107260 and acetyl-arginyl-glycyl-aspartyl-serinamide

ArticleYear
Design and synthesis of a C7 mimetic for the predicted gamma-turn conformation found in several constrained RGD antagonists.
    Journal of medicinal chemistry, 1992, Oct-16, Volume: 35, Issue:21

    Topics: Amino Acid Sequence; Drug Design; Fibrinogen; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Conformation

1992